The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus ; volume:8 ; number:1 ; day:6 ; month:2 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (6.2.2018), 1-10, 12.2018

Keyword: Krebs
Onkologie

Creator: Yeo, Won-Sik

Contributor: Arya, Rekha
Kim, Kyeong Kyu
Jeong, Hyunyoung
Cho, Kyu Hong
Bae, Taeok
SpringerLink (Online service)

DOI: 10.1038/s41598-018-20617-5

URN: urn:nbn:de:1111-20180328787

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Yeo, Won-Sik
Arya, Rekha
Kim, Kyeong Kyu
Jeong, Hyunyoung
Cho, Kyu Hong
Bae, Taeok
SpringerLink (Online service)

Other Objects (12)

A systematic analysis of FDA-approved anticancer drugs

Classification of anticancer drugs: an update with FDA- and EMA-approved drugs

Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Hochschulschrift

Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus

FDA‐approved drugs featuring macrocycles or medium‐sized rings

Synthesis of the First FDA-Approved HIV Protease Inhibitor

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

FDA-approved disulfiram as a novel treatment for aggressive leukemia

Identification of FDA-approved drugs targeting the Farnesoid X Receptor

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics

A systematic analysis of FDA-approved anticancer drugs

Classification of anticancer drugs: an update with FDA- and EMA-approved drugs

Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Hochschulschrift

Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus

FDA‐approved drugs featuring macrocycles or medium‐sized rings

Synthesis of the First FDA-Approved HIV Protease Inhibitor

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

FDA-approved disulfiram as a novel treatment for aggressive leukemia

Identification of FDA-approved drugs targeting the Farnesoid X Receptor

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics

A systematic analysis of FDA-approved anticancer drugs

Classification of anticancer drugs: an update with FDA- and EMA-approved drugs

Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Hochschulschrift

Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus

FDA‐approved drugs featuring macrocycles or medium‐sized rings

Synthesis of the First FDA-Approved HIV Protease Inhibitor

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

FDA-approved disulfiram as a novel treatment for aggressive leukemia

Identification of FDA-approved drugs targeting the Farnesoid X Receptor

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

A systematic analysis of FDA-approved anticancer drugs

Classification of anticancer drugs: an update with FDA- and EMA-approved drugs

Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus

FDA‐approved drugs featuring macrocycles or medium‐sized rings

Synthesis of the First FDA-Approved HIV Protease Inhibitor

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

FDA-approved disulfiram as a novel treatment for aggressive leukemia

Identification of FDA-approved drugs targeting the Farnesoid X Receptor

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics

A systematic analysis of FDA-approved anticancer drugs

Classification of anticancer drugs: an update with FDA- and EMA-approved drugs

Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus

FDA‐approved drugs featuring macrocycles or medium‐sized rings

Synthesis of the First FDA-Approved HIV Protease Inhibitor

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

FDA-approved disulfiram as a novel treatment for aggressive leukemia

Identification of FDA-approved drugs targeting the Farnesoid X Receptor

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics

A systematic analysis of FDA-approved anticancer drugs

Classification of anticancer drugs: an update with FDA- and EMA-approved drugs

Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs

The First FDA-Approved Antibody-Drug Conjugate

Repurposing FDA-approved drugs for anti-aging therapies

Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus

FDA‐approved drugs featuring macrocycles or medium‐sized rings

Synthesis of the First FDA-Approved HIV Protease Inhibitor

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

FDA-approved disulfiram as a novel treatment for aggressive leukemia

Identification of FDA-approved drugs targeting the Farnesoid X Receptor

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics

Related objects

Reset password